Cullinan Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.99M | Sell |
46,620
-1,425
| -3% | -$167K | 0.45% | 55 |
|
|
2026
Q1 | $5.78M | Sell |
48,045
-2,489
| -5% | -$287K | 0.47% | 55 |
|
|
2025
Q4 | $5.32M | Buy |
50,534
+910
| +2% | +$85.4K | 0.36% | 60 |
|
|
2025
Q3 | $4.16M | Buy |
49,624
+30
| +0.1% | +$2.47K | 0.27% | 69 |
|
|
2025
Q2 | $3.93M | Buy |
49,594
+4,275
| +9% | +$340K | 0.26% | 72 |
|
|
2025
Q1 | $4.07M | Buy |
45,319
+441
| +1% | +$41.2K | 0.29% | 76 |
|
|
2024
Q4 | $4.46M | Sell |
44,878
-1,390
| -3% | -$143K | 0.29% | 69 |
|
|
2024
Q3 | $4.94M | Buy |
46,268
+2,300
| +5% | +$273K | 0.28% | 75 |
|
|
2024
Q2 | $5.44M | Buy |
43,968
+3,720
| +9% | +$479K | 0.31% | 66 |
|
|
2024
Q1 | $5.31M | Sell |
40,248
-18,731
| -32% | -$2.31M | 0.3% | 70 |
|
|
2023
Q4 | $6.43M | Sell |
58,979
-6,284
| -10% | -$652K | 0.36% | 64 |
|
|
2023
Q3 | $6.72M | Sell |
65,263
-6,481
| -9% | -$699K | 0.39% | 61 |
|
|
2023
Q2 | $8.28M | Sell |
71,744
-5,102
| -7% | -$579K | 0.46% | 60 |
|
|
2023
Q1 | $8.18M | Buy |
76,846
+20,104
| +35% | +$2.17M | 0.48% | 58 |
|
|
2022
Q4 | $6.3M | Buy |
56,742
+2,923
| +5% | +$299K | 0.35% | 67 |
|
|
2022
Q3 | $4.63M | Buy |
53,819
+7,276
| +16% | +$650K | 0.29% | 82 |
|
|
2022
Q2 | $4.24M | Sell |
46,543
-5,440
| -10% | -$482K | 0.26% | 86 |
|
|
2022
Q1 | $4.26M | Buy |
51,983
+9,460
| +22% | +$746K | 0.22% | 98 |
|
|
2021
Q4 | $3.26M | Sell |
42,523
-68,210
| -62% | -$5.43M | 0.17% | 111 |
|
|
2021
Q3 | $8.32M | Sell |
110,733
-1,046
| -0.9% | -$79.6K | 0.46% | 61 |
|
|
2021
Q2 | $8.69M | Sell |
111,779
-22,133
| -17% | -$1.65M | 0.49% | 63 |
|
|
2021
Q1 | $9.85M | Sell |
133,912
-404
| -0.3% | -$29.8K | 0.57% | 52 |
|
|
2020
Q4 | $10.5M | Buy |
134,316
+3,860
| +3% | +$295K | 0.63% | 41 |
|
|
2020
Q3 | $10.3M | Buy |
130,456
+28,899
| +28% | +$2.26M | 0.67% | 32 |
|
|
2020
Q2 | $7.49M | Sell |
101,557
-11,864
| -10% | -$893K | 0.53% | 44 |
|
|
2020
Q1 | $8.33M | Sell |
113,421
-3,656
| -3% | -$287K | 0.68% | 35 |
|
|
2019
Q4 | $10.2M | Sell |
117,077
-1,301
| -1% | -$107K | 0.68% | 37 |
|
|
2019
Q3 | $9.51M | Sell |
118,378
-209
| -0.2% | -$16.8K | 0.68% | 42 |
|
|
2019
Q2 | $9.49M | Sell |
118,587
-7,389
| -6% | -$566K | 0.69% | 38 |
|
|
2019
Q1 | $10M | Buy |
125,976
+1,520
| +1% | +$114K | 0.75% | 31 |
|
|
2018
Q4 | $9.07M | Sell |
124,456
-4,140
| -3% | -$292K | 0.75% | 29 |
|
|
2018
Q3 | $8.71M | Sell |
128,596
-36,680
| -22% | -$2.34M | 0.63% | 42 |
|
|
2018
Q2 | $9.57M | Sell |
165,276
-7,126
| -4% | -$402K | 0.73% | 31 |
|
|
2018
Q1 | $8.96M | Sell |
172,402
-582
| -0.3% | -$31.4K | 0.68% | 35 |
|
|
2017
Q4 | $9.29M | Sell |
172,984
-68,330
| -28% | -$3.79M | 0.68% | 36 |
|
|
2017
Q3 | $14.7M | Sell |
241,314
-314
| -0.1% | -$19K | 1.14% | 14 |
|
|
2017
Q2 | $14.8M | Buy |
241,628
+7,381
| +3% | +$449K | 1.15% | 14 |
|
|
2017
Q1 | $14.2M | Buy |
234,247
+584
| +0.2% | +$35.4K | 1.16% | 14 |
|
|
2016
Q4 | $13.1M | Buy |
233,663
+3,039
| +1% | +$178K | 1.12% | 15 |
|
|
2016
Q3 | $13.7M | Sell |
230,624
-11,633
| -5% | -$680K | 1.17% | 13 |
|
|
2016
Q2 | $13.3M | Buy |
242,257
+4,245
| +2% | +$226K | 1.08% | 16 |
|
|
2016
Q1 | $12M | Sell |
238,012
-4,609
| -2% | -$226K | 1.03% | 16 |
|
|
2015
Q4 | $12.2M | Sell |
242,621
-3,019
| -1% | -$152K | 1.06% | 18 |
|
|
2015
Q3 | $11.6M | Buy |
245,640
+89,389
| +57% | +$4.75M | 1.06% | 15 |
|
|
2015
Q2 | $8.49M | Buy |
156,251
+4,350
| +3% | +$244K | 0.7% | 30 |
|
|
2015
Q1 | $8.33M | Sell |
151,901
-48,548
| -24% | -$2.75M | 0.65% | 35 |
|
|
2014
Q4 | $10.9M | Buy |
200,449
+12,194
| +6% | +$679K | 1.15% | 13 |
|
|
2014
Q3 | $10.6M | Buy |
188,255
+34,411
| +22% | +$1.93M | 1.21% | 12 |
|
|
2014
Q2 | $6.82M | Sell |
153,844
-38,960
| -20% | -$2.13M | 1.11% | 8 |
|
|
2014
Q1 | $10.4M | Sell |
192,804
-12,523
| -6% | -$648K | 1.19% | 12 |
|
|
2013
Q4 | $9.81M | Buy |
205,327
+17,161
| +9% | +$784K | 1.14% | 11 |
|
|
2013
Q3 | $8.55M | Sell |
188,166
-1,048
| -0.6% | -$47.8K | 1.15% | 11 |
|
|
2013
Q2 | $8.39M | Buy |
+189,214
| New | +$8.45M | 1.13% | 10 |
|
Other funds holding MRK
ECSS
ATO
Cullinan Associates's MRK Position: Q2 2026 in Review
Cullinan Associates reduced its Merck (MRK) stake by 3% in Q2 2026, selling an estimated $167K and leaving 46,620 shares worth $5.99M. The position accounts for 0.45% of the portfolio, ranked #55.
Cullinan Associates first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.8M in Q2 2017. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Cullinan Associates held 46,620 shares of Merck worth $5.99M as of Q2 2026.
- Cullinan Associates sold 1,425 Merck shares in Q2 2026, an estimated $167K.
- Merck made up 0.45% of Cullinan Associates's portfolio in Q2 2026, its #55 holding.
- Cullinan Associates first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Cullinan Associates's Merck position peaked at $14.8M in Q2 2017.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Cullinan Associates's 13F filing for Q2 2026, filed 29 Jul 2026.